Back to Journals » Lung Cancer: Targets and Therapy » Volume 1 » Default
Review
Standing the test of time in Europe? Gefitinib in the treatment of non-small-cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,541 | Dovepress* | 6,541+ | 2,465 | 9,006 | |
Totals | 6,541 | 2,465 | 9,006 | ||
*Since 13 May 2010 +Since July 2016 |
View citations on Google Scholar